 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Previous Article | Next Article
The Journal of Neuroscience, January 1, 2002, 22(1):193-199
Mice Deficient for Both Corticotropin-Releasing Factor Receptor 1 (CRFR1) and CRFR2 Have an Impaired Stress Response and Display Sexually Dichotomous Anxiety-Like Behavior
Tracy L. Bale1, Roberto Picetti2, Angelo Contarino2, George F. Koob2, Wylie W. Vale1, and Kuo-Fen Lee1 1 Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, California 92037, and 2 Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California 92037
Corticotropin-releasing factor (CRF) and its family of peptides are critical coordinators of homeostasis whose actions are mediated through their receptors, CRF receptor 1 (CRFR1) and CRFR2, found throughout the CNS and periphery. The phenotypes of mice deficient in either CRFR1 or CRFR2 demonstrate the critical role these receptors play. CRFR1-mutant mice have an impaired stress response and display decreased anxiety-like behavior, whereas CRFR2-mutant mice are hypersensitive to stress and display increased anxiety-like behavior. To further elucidate the roles of both CRF receptors and determine their interaction in behaviors, we have generated mice deficient in both CRFR1 and CRFR2. The behavioral phenotype of these mice demonstrates a novel role of the mother's genotype on development of pup anxiety. We have found that although the female double-mutant mice display anxiolytic-like behavior, the male double-mutant mice show significantly more anxiety-like behavior compared with the females. We have also determined that the dam's CRFR2 genotype affects the anxiety-like behavior of the male mice, such that a pup born to a heterozygous or mutant dam displays significantly more anxiety-like behavior regardless of that pup's genotype. Double-mutant mice also display an even greater impairment of their hypothalamic-pituitary-adrenal axis response to stress than that of the CRFR1-mutant mice. CRF mRNA levels are elevated in CRFR1- and double-mutant mice, and urocortin III and vasopressin mRNA levels are increased in CRFR2- and double-mutant mice. These results indicate that both CRFR1 and CRFR2 have critical roles in gene regulation and the maintenance of homeostasis in response to stress.
Key words: corticotropin-releasing factor; urocortin; urocortin III; maternal genotype; anxiety; stress
Copyright © 2002 Society for Neuroscience 0270-6474/02/221193-07$05.00/0
This article has been cited by other articles:
J. G. McEuen, K. A. Semsar, M. A. Lim, and T. L. Bale
Influence of Sex and Corticotropin-Releasing Factor Pathways as Determinants in Serotonin Sensitivity
Endocrinology, August 1, 2009; 150(8): 3709 - 3716.
[Abstract] [Full Text] [PDF]
J. G. McEuen, S. G. Beck, and T. L. Bale
Failure to Mount Adaptive Responses to Stress Results in Dysregulation and Cell Death in the Midbrain Raphe
J. Neurosci., August 13, 2008; 28(33): 8169 - 8177.
[Abstract] [Full Text] [PDF]
J. A Majzoub
Corticotropin-releasing hormone physiology
Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S71 - S76.
[Abstract] [Full Text] [PDF]
E Zoumakis, D K Grammatopoulos, and G P Chrousos
Corticotropin-releasing hormone receptor antagonists
Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S85 - S91.
[Abstract] [Full Text] [PDF]
T. Fukuda, K. Takahashi, T. Suzuki, M. Saruta, M. Watanabe, T. Nakata, and H. Sasano
Urocortin 1, Urocortin 3/Stresscopin, and Corticotropin-Releasing Factor Receptors in Human Adrenal and Its Disorders
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4671 - 4678.
[Abstract] [Full Text] [PDF]
S. C. Gammie
Current Models and Future Directions for Understanding the Neural Circuitries of Maternal Behaviors in Rodents
Behav Cogn Neurosci Rev, June 1, 2005; 4(2): 119 - 135.
[Abstract] [PDF]
D. Refojo, C. Echenique, M. B. Muller, J. M. H. M. Reul, J. M. Deussing, W. Wurst, I. Sillaber, M. Paez-Pereda, F. Holsboer, and E. Arzt
Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas
PNAS, April 26, 2005; 102(17): 6183 - 6188.
[Abstract] [Full Text] [PDF]
A. R. Ayala, J. Pushkas, J. D. Higley, D. Ronsaville, P. W. Gold, G. P. Chrousos, K. Pacak, K. A. Calis, M. Gerald, S. Lindell, et al.
Behavioral, Adrenal, and Sympathetic Responses to Long-Term Administration of an Oral Corticotropin-Releasing Hormone Receptor Antagonist in a Primate Stress Paradigm
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5729 - 5737.
[Abstract] [Full Text] [PDF]
S. C. Heinrichs and G. F. Koob
Corticotropin-Releasing Factor in Brain: A Role in Activation, Arousal, and Affect Regulation
J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 427 - 440.
[Abstract] [Full Text] [PDF]
D. S. Charney
Psychobiological Mechanisms of Resilience and Vulnerability: Implications for Successful Adaptation to Extreme Stress
Focus, July 1, 2004; 2(3): 368 - 391.
[Abstract] [Full Text] [PDF]
Y Tache
Corticotropin releasing factor receptor antagonists: potential future therapy in gastroenterology?
Gut, July 1, 2004; 53(7): 919 - 921.
[Full Text] [PDF]
V. Martinez, L. Wang, J. Rivier, D. Grigoriadis, and Y. Tache
Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice
J. Physiol., April 1, 2004; 556(1): 221 - 234.
[Abstract] [Full Text] [PDF]
D. S. Charney
Psychobiological Mechanisms of Resilience and Vulnerability: Implications for Successful Adaptation to Extreme Stress
Am J Psychiatry, February 1, 2004; 161(2): 195 - 216.
[Abstract] [Full Text] [PDF]
K. Isogawa, J. Akiyoshi, T. Tsutsumi, K. Kodama, Y. Horinouti, and H. Nagayama
Anxiogenic-Like Effect of Corticotropin-Releasing Factor Receptor 2 Antisense Oligonucleotides Infused into Rat Brain
J Psychopharmacol, December 1, 2003; 17(4): 409 - 413.
[Abstract] [PDF]
A. Chen, J. Vaughan, and W. W. Vale
Glucocorticoids Regulate the Expression of the Mouse Urocortin II Gene: A Putative Connection between the Corticotropin-Releasing Factor Receptor Pathways
Mol. Endocrinol., August 1, 2003; 17(8): 1622 - 1639.
[Abstract] [Full Text] [PDF]
T. L. Bale and W. W. Vale
Increased Depression-Like Behaviors in Corticotropin-Releasing Factor Receptor-2-Deficient Mice: Sexually Dichotomous Responses
J. Neurosci., June 15, 2003; 23(12): 5295 - 5301.
[Abstract] [Full Text] [PDF]
C. L. Rivier, D. E. Grigoriadis, and J. E. Rivier
Role of Corticotropin-Releasing Factor Receptors Type 1 and 2 in Modulating the Rat Adrenocorticotropin Response to Stressors
Endocrinology, June 1, 2003; 144(6): 2396 - 2403.
[Abstract] [Full Text] [PDF]
T. L. Bale, K. R. Anderson, A. J. Roberts, K.-F. Lee, T. R. Nagy, and W. W. Vale
Corticotropin-Releasing Factor Receptor-2-Deficient Mice Display Abnormal Homeostatic Responses to Challenges of Increased Dietary Fat and Cold
Endocrinology, June 1, 2003; 144(6): 2580 - 2587.
[Abstract] [Full Text] [PDF]
S. E. Hammack, M. J. Schmid, M. L. LoPresti, A. Der-Avakian, M. A. Pellymounter, A. C. Foster, L. R. Watkins, and S. F. Maier
Corticotropin Releasing Hormone Type 2 Receptors in the Dorsal Raphe Nucleus Mediate the Behavioral Consequences of Uncontrollable Stress
J. Neurosci., February 1, 2003; 23(3): 1019 - 1025.
[Abstract] [Full Text] [PDF]
O. A. Tjurmina, I. Armando, J. M. Saavedra, D. S. Goldstein, and D. L. Murphy
Exaggerated Adrenomedullary Response to Immobilization in Mice with Targeted Disruption of the Serotonin Transporter Gene
Endocrinology, December 1, 2002; 143(12): 4520 - 4526.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|